TRVI · Trevi Therapeutics, Inc. · Investor Relations

$12.94 +0.17 (+1.33%) At close · Oct 22

Russell 2000 member Rebalance outlook locked

Market Cap

$1.85B

142.48M

Volume · Oct 22 1.18M Avg daily vol (3M) 1.97M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-09-16	Morgan Stanley 24th Annual Global Healthcare Conference	Conference
2026-09-16	H.C. Wainwright 28th Annual Global Investment Conference	Conference
2026-09-11	2026 Cantor Global Healthcare Conference	Conference
2026-08-06	Trevi Therapeutics, Inc. 2Q 2026 Financial Results	Earnings call
2026-05-18	Trevi Therapeutics: Data Highlights from Trevi’s ATS 2026 Presentations	Presentation
2026-05-13	Bank of America Global Healthcare Conference 2026	Conference
2026-05-07	Trevi Therapeutics, Inc – Investor and Analyst Day	Presentation
2026-05-05	Trevi Therapeutics, Inc. 1Q 2026 Financial Results	Earnings call
2026-03-17	Trevi Therapeutics, Inc. 4Q and YE 2025 Financial Results	Earnings call
2026-03-11	Leerink Partners 2026 Global Healthcare Conference	Conference
2025-11-13	Trevi Therapeutics, Inc. - 3Q 2025 Financial Results	Event
2025-09-10	Morgan Stanley 23rd Annual Global Healthcare Conference	Conference
2025-08-07	Trevi Therapeutics, Inc. - 2Q 2025 Financial Results	Event
2025-06-02	Phase 2b CORAL Trial - Topline Results Webcast	Earnings call

Source: https://ir.trevitherapeutics.com/

Key facts CIK 1563880 CUSIP 89532M101 13F (30d) 18 filings 18 filers Visit website Investor relations